Buchanan Ingersoll Disqualified From Ritalin Suit
After escaping sanctions in the patent battle over a generic version of Ritalin LA, Celgene Corp. has won a bid to have Buchanan Ingersoll & Rooney PC booted from representing opponent...To view the full article, register now.
Already a subscriber? Click here to view full article